>>14041989>>14042051The more fucked up thing is this
>At this time, Sotrovimab (Xevudy) is the only authorized monoclonal antibody product expected to be effective against the omicron variant of SARS-CoV-2.>There is a pause on allocations of bamlanivimab and etesevimab together, etesevimab alone, and REGEN-COV until further notice. These products do not retain activity against omicron and should not be used.They are pretending Omicron is the only variant.
Even if it is the dominant variant in the POPULATION, Delta is still the dominant variant in HOSPITALIZATIONS
Another line:
>At this time, Sotrovimab (Xevudy) is the only authorized monoclonal antibody therapeutic that is expected to be effective against the omicron variant of SARS-CoV-2.>Supplies of Sotrovimab are extremely limited and providers should adhere to NYS DOH prioritization guidance, and refer to the NYC Health Department’s Letter to Providers: Omicron and Monoclonal Antibodies.They have created a shortage then used the shortage to force race-based triage.
Here's a fun one from JAMA
https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2785980>Findings: In this systematic review and meta-analysis of 4.3 million patients from 68 studies, African American, Hispanic, and Asian American individuals had a higher risk of COVID-19 positivity and ICU admission but lower mortality rates than White individuals. Socioeconomic disparity and clinical care quality were associated with COVID-19 mortality and incidence in racial and ethnic minority groups.MINORITEIS HAVE A LOWER MORTALITY RATE THAN WHITES
But here is how they want you to interpret the findings:
>Meaning: In this study, members of racial and ethnic minority groups had higher rates of COVID-19 positivity and disease severity than White populationsSOMEHOW LOWER MORTALITY RATES MEANS HIGHER SEVERITY
